Skip to Content
Merck
  • Screening methodologies for the development of spray-dried amorphous solid dispersions.

Screening methodologies for the development of spray-dried amorphous solid dispersions.

Pharmaceutical research (2014-08-20)
Íris Duarte, José Luís Santos, João F Pinto, Márcio Temtem
ABSTRACT

To present a new screening methodology intended to be used in the early development of spray-dried amorphous solid dispersions. A model that combines thermodynamic, kinetic and manufacturing considerations was implemented to obtain estimates of the miscibility and phase behavior of different itraconazole-based solid dispersions. Additionally, a small-scale solvent casting protocol was developed to enable a fast assessment on the amorphous stability of the different drug-polymer systems. Then, solid dispersions at predefined drug loads were produced in a lab-scale spray dryer for powder characterization and comparison of the results generated by the model and solvent cast samples. The results obtained with the model enabled the ranking of the polymers from a miscibility standpoint. Such ranking was consistent with the experimental data obtained by solvent casting and spray drying. Moreover, the range of optimal drug load determined by the model was as well consistent with the experimental results. The screening methodology presented in this work showed that a set of amorphous formulation candidates can be assessed in a computer model, enabling not only the determination of the most suitable polymers, but also of the optimal drug load range to be tested in laboratory experiments. The set of formulation candidates can then be further fine-tuned with solvent casting experiments using a small amount of API, which will then provide the decision for the final candidate formulations to be assessed in spray drying experiments.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Methyl methacrylate, contains ≤30 ppm MEHQ as inhibitor, 99%
Sigma-Aldrich
Methyl methacrylate, 99%, stabilized
Methyl methacrylate, European Pharmacopoeia (EP) Reference Standard
Butyl methacrylate, European Pharmacopoeia (EP) Reference Standard
2-(Dimethylamino)ethyl methacrylate, European Pharmacopoeia (EP) Reference Standard
Vinyl acetate, European Pharmacopoeia (EP) Reference Standard
Supelco
Vinyl acetate, analytical standard
Sigma-Aldrich
2-(Dimethylamino)ethyl methacrylate, contains 700-1000 ppm monomethyl ether hydroquinone as inhibitor, 98%
Sigma-Aldrich
Vinyl acetate, contains 3-20 ppm hydroquinone as inhibitor, ≥99%
Sigma-Aldrich
Butyl methacrylate, 99%, contains monomethyl ether hydroquinone as inhibitor